Growing community of inventors

Sudbury, MA, United States of America

Paul D Rubin

Average Co-Inventor Count = 1.89

ph-index = 10

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 327

Paul D RubinTimothy J Barberich (15 patents)Paul D RubinThomas P Jerussi (8 patents)Paul D RubinWilliam E Yelle (5 patents)Paul D RubinChrisantha Hugh Senanayake (4 patents)Paul D RubinFran A McConville (4 patents)Paul D RubinRoger P Bakale (3 patents)Paul D RubinYaping Hong (3 patents)Paul D RubinDean A Handley (3 patents)Paul D RubinTingjian Xiang (3 patents)Paul D RubinMark G Currie (2 patents)Paul D RubinJohn R McCullough (2 patents)Paul D RubinChris Hugh Senanayake (1 patent)Paul D RubinPatrick Koch (1 patent)Paul D RubinFran A Mcconville (1 patent)Paul D RubinPaul D Rubin (36 patents)Timothy J BarberichTimothy J Barberich (32 patents)Thomas P JerussiThomas P Jerussi (53 patents)William E YelleWilliam E Yelle (18 patents)Chrisantha Hugh SenanayakeChrisantha Hugh Senanayake (24 patents)Fran A McConvilleFran A McConville (4 patents)Roger P BakaleRoger P Bakale (25 patents)Yaping HongYaping Hong (13 patents)Dean A HandleyDean A Handley (5 patents)Tingjian XiangTingjian Xiang (3 patents)Mark G CurrieMark G Currie (70 patents)John R McCulloughJohn R McCullough (32 patents)Chris Hugh SenanayakeChris Hugh Senanayake (4 patents)Patrick KochPatrick Koch (11 patents)Fran A McconvilleFran A Mcconville (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sepracor, Inc. (33 from 322 patents)

2. Other (1 from 832,680 patents)

3. Sunovion Pharmaceuticals Inc. (1 from 130 patents)

4. Swpracor, Inc. (1 from 1 patent)


36 patents:

1. 8404715 - Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors

2. 7064138 - Methods for treating irritable bowel syndrome using optically pure (-) norcisapride

3. 7030142 - Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites

4. 6946464 - Methods of treating and preventing a convulsive state

5. 6835740 - Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride

6. 6790849 - Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants

7. 6649183 - Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron

8. 6620851 - Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen

9. 6586437 - (S)-hydroxynefazodone antipsychotic therapy

10. 6559165 - Methods for treating bulimia using optically pure (−) norcisapride

11. 6552045 - Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists

12. 6548082 - Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron

13. 6548518 - Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists

14. 6509353 - Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors

15. 6506753 - Methods of making and using N-desmethylzopiclone

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…